๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Estrogens and benign prostatic hyperplasia: The basis for aromatase inhibitor therapy

โœ Scribed by D. Henderson; U.-F. Habenicht; Y. Nishino; M.F El Etreby


Book ID
116065057
Publisher
Elsevier Science
Year
1987
Tongue
English
Weight
895 KB
Volume
50
Category
Article
ISSN
0039-128X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Estrogen reduction by aromatase inhibiti
โœ Radlmaier, Albert; Eickenberg, Hans U.; Fletcher, Matthew S.; Fourcade, Richard ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 799 KB

## BACKGROUND. The concept of estrogen withdrawal by an aromatase inhibitor in the treatment of benign prostatic hyperplasia (BPH) was assessed in a prospective, randomized, double-blind, placebo-controlled multicenter trial. METHODS. Two hundred and ninety-two patients with clinical symptoms of B